TRIM8 enhances chondrocyte ferroptosis by inhibiting YTHDF2-m6A mediated SREBF2 mRNA degradation to promote OA progression
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.114441 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Ruoxi Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, the Second Affiliated Hospital of Xi'an JiaoTong University, Xi'an, China. Hauptthemen laut MEDLINE: Ferroptosis, Chondrocytes, Osteoarthritis, RNA-Binding Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Xi’an Jiaotong University.
Abstract (Originalsprache)
Chondrocyte ferroptosis plays a crucial role in osteoarthritis (OA) progression. Our previous study demonstrated that TRIM8 knockdown alleviated IL-1β-induced chondrocyte injury. However, the involvement of TRIM8 in regulating OA progression through ferroptosis remains unclear. In this study, human OA and normal cartilage samples were collected to examine ferroptosis and TRIM8 expression. We found that both ferroptosis markers and TRIM8 protein levels were elevated in OA cartilage compared to controls. An OA cell model was established by stimulating chondrocytes with IL-1β. TRIM8 knockdown mitigated IL-1β-induced ferroptosis, extracellular matrix (ECM) degradation, and inflammation in chondrocytes. Mechanistically, TRIM8 facilitated the ubiquitylation of YTHDF2 via its RING domain, promoting YTHDF2 protein degradation. This inhibited YTHDF2-m6A-induced SREBF2 mRNA degradation, thereby upregulating SREBF2 expression and enhancing chondrocyte ferroptosis. As expected, SREBF2 overexpression reversed the protective effect of TRIM8 silencing on IL-1β-induced chondrocyte injury. An OA mouse model was established using destabilized medial meniscus surgery, and TRIM8 deficiency alleviated cartilage degradation and synovial inflammation. In conclusion, TRIM8 promotes chondrocyte ferroptosis by suppressing YTHDF2-m6A mediated SREBF2 mRNA degradation, thereby accelerating OA progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, the Second Affiliated Hospital of Xi'an JiaoTong University, Xi'an, China.
- Shaanxi Provincial Center for Disease Control and Prevention, Xi'an, China.
- Shaanxi Provincial Center for Disease Control and Prevention, Xi'an, China. Electronic address: esbo142@163.com.
- Department of Orthopaedics, the Second Affiliated Hospital of Xi'an JiaoTong University, Xi'an, China. Electronic address: song_huanjin@163.com.
Förderung
- Xi’an Jiaotong University
Zitieren
APA
Liu, R., Xiao, Y., Zhang, G., Han, P., Lin, Z., & Song, H. (2025). TRIM8 enhances chondrocyte ferroptosis by inhibiting YTHDF2-m6A mediated SREBF2 mRNA degradation to promote OA progression. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114441
Vancouver
Liu R, Xiao Y, Zhang G, Han P, Lin Z, Song H. TRIM8 enhances chondrocyte ferroptosis by inhibiting YTHDF2-m6A mediated SREBF2 mRNA degradation to promote OA progression. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114441
BibTeX
@article{Liu2025,
author = {Liu, Ruoxi and Xiao, Yi and Zhang, Gelin and Han, Pei and Lin, Zhaoxing and Song, Huanjin},
title = {TRIM8 enhances chondrocyte ferroptosis by inhibiting YTHDF2-m6A mediated SREBF2 mRNA degradation to promote OA progression},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.114441}
}
EUVIMED